These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38159017)

  • 21. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study.
    Henneicke-von Zepelin H; Hentschel C; Schnitker J; Kohnen R; Köhler G; Wüstenberg P
    Curr Med Res Opin; 1999; 15(3):214-27. PubMed ID: 10621929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.
    Bodemer C; Guillet G; Cambazard F; Boralevi F; Ballarini S; Milliet C; Bertuccio P; La Vecchia C; Bach JF; de Prost Y
    PLoS One; 2017; 12(3):e0161555. PubMed ID: 28333952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
    Mukherjee PK; Esper F; Buchheit K; Arters K; Adkins I; Ghannoum MA; Salata RA
    BMC Infect Dis; 2017 Jan; 17(1):74. PubMed ID: 28088167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.
    Lindberg BF; Nelson I; Ranstam J; Riker DK
    PLoS One; 2023; 18(1):e0279204. PubMed ID: 36652464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.
    Grebe W; Ionescu E; Gold MS; Liu JM; Frank WO
    Clin Ther; 2003 Feb; 25(2):444-58. PubMed ID: 12749506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial.
    McElhaney JE; Goel V; Toane B; Hooten J; Shan JJ
    J Altern Complement Med; 2006 Mar; 12(2):153-7. PubMed ID: 16566675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Aviron Rapid® in 18-60-year-old patients with clinical diagnosis of acute respiratory viral infection: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Popov G; Gospodinova-Bliznakova M; Kalvatchev Z; Tchorbanov A
    Folia Med (Plovdiv); 2021 Feb; 63(1):129-137. PubMed ID: 33650407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C; Gentile DA; Skoner DP
    Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial.
    Li W; Xie L; Zhu X; Yang Y; Wang L; Yang M; Li H; Li X; Yan G; Wu X; Zhao W; Zhang J; Yang G; Guo Y; Li C; Wang R; Shi L; Xiong Z; Xu P; Kong W; Cui M; Yang X; Ba Y
    Front Pharmacol; 2023; 14():1133560. PubMed ID: 37007028
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.
    Gutiérrez-Tarango MD; Berber A
    Chest; 2001 Jun; 119(6):1742-8. PubMed ID: 11399700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.
    Hershberger E; Sloan S; Narayan K; Hay CA; Smith P; Engler F; Jeeninga R; Smits S; Trevejo J; Shriver Z; Oldach D
    EBioMedicine; 2019 Feb; 40():574-582. PubMed ID: 30638863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.
    de Boer GM; Braunstahl GJ; van der Ploeg EK; van Zelst CM; van Bruggen A; Epping G; van Nimwegen M; Verhoeven G; Birnie E; Boxma-de Klerk BM; de Bruijn MJW; Stadhouders R; Hendriks RW; Tramper-Stranders GA
    Clin Exp Allergy; 2021 Sep; 51(9):1172-1184. PubMed ID: 34289183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.